PMEF
RETA

Point72 Middle East FZE’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Point72 Middle East FZE’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,354
Closed -$127K – 1786
2022
Q4 		$127K Buy
+3,354
New +$127K 0.01% 689